New research analysis affirms the addition of the following structure function claims for VINIA® according to FDA Guidelines for Dietary Supplements: VINIA® prevents Lipid Oxidation VINIA®...
Steven Lehrer’s 40 years of Biotech experience enhances the board of advisors with expertise in pharmaceutical, biopharmaceutical, and biosimilar R&D. His appointment continues to demonstrate the...
David Tsur’s 40 years of Biotech experience further strengthens the Board at a critical phase of the Company’s growth His appointment reinforces the Company’s primary focus...
Vancouver, Canada, and Rehovot, Israel–(Newsfile Corp. – October 13, 2021) – BioHarvest Sciences Inc. (CSE: BHSC) (FSE: 8MV) (“BioHarvest” or the “Company”) today announces an update...
Vancouver, British Columbia and Rehovot, Israel–(Newsfile Corp. – October 12, 2021) – BioHarvest Sciences Inc. (CSE: BHSC) (FSE: 8MV) (“BioHarvest” or the “Company”) invites its shareholders and...
Total of CAD$ 7,909,064 raised from private placement and warrants exercised Vancouver, British Columbia and Rehovot, Israel–(Newsfile Corp. – October 4, 2021) – BioHarvest Sciences Inc. (CSE:...
First tranche closed represents over three-quarters of the anticipated financing. Vancouver, British Columbia and Rehovot, Israel–(Newsfile Corp. – August 30, 2021) – BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest”...
Vancouver, British Columbia–(Newsfile Corp. – July 2, 2021) – BioHarvest Sciences Inc. (CSE: BHSC) (the “Company”, “BioHarvest”) invites its shareholders and the general public to join a Live...
VINIA(R)’s ability to increase dilation of arteries and to reduce blood vessel constriction allows it to fight the human aging process Vancouver, British Columbia–(Newsfile Corp. –...
Staying on course for the commercialization of Cannabis & Hemp Products in the first half of 2022 Vancouver, British Columbia–(Newsfile Corp. – June 8, 2021) –...